Dr. Khawla Sami Al-Kuraya is a Saudi physician-scientist whose work has helped define the field of cancer genomics in the Kingdom. As Chief Cancer Research Scientist at King Faisal Specialist Hospital & Research Centre (Riyadh), she leads major research programs that examine the genetic foundations of cancer and their clinical implications.
Her research bridges laboratory science and clinical medicine, with a focus on identifying the molecular signatures of tumors in Saudi populations. Through this work, she has helped strengthen Saudi Arabia’s position in global cancer genomics research.
Sharpened by Experience
Dr. Al-Kuraya was born in Al-Jawf in northern Saudi Arabia, where she completed her early education before pursuing medicine. Her academic pathway reflects a strong integration of clinical training and molecular research. Her education and training include:
- 1994 — Bachelor of Medicine and Surgery (MBBS), King Saud University, Riyadh, Saudi Arabia
- Residency in Pathology, Georgetown University Hospital, Washington, DC, United States
- 2000 — American Board Certification in Pathology, Georgetown University
- 2001 — Fellowship in Cancer Genetics, National Cancer Institute, Maryland, United States
After completing her medical degree, she was appointed as a teaching assistant at King Saud University and was later sponsored for advanced training in the United States. During this period, she specialized in genetics and molecular diagnostics. Her training at Georgetown University and the National Cancer Institute introduced her to emerging genomic technologies that were beginning to reshape cancer research. These experiences would later shape her scientific focus on cancer genomics and molecular pathology.
Clinical Expertise in Cancer Genomics
Dr. Khawla Al-Kuraya’s research centers on molecular oncology, the study of genetic alterations that influence how cancer develops and progresses. Her work focuses on identifying genetic patterns within tumors, sometimes called molecular signatures, which help researchers understand why cancers behave differently across populations. Her research expertise includes two main areas.
Cancer genomics and molecular profiling
- Identification of cancer-related gene mutations
- Molecular characterization of tumors in Saudi patients
- Genomic studies of breast and thyroid cancers
- Population-based cancer genetics research
Translational cancer research
- Connecting genomic discoveries with clinical oncology
- Development of diagnostic genetic testing tools
- Precision medicine approaches to cancer treatment
- Building genomic databases for regional tumor research
Dr. Al-Kuraya has authored nearly 400 scientific and research publications, contributing to the global scientific literature on cancer genetics and molecular oncology. Her work often emphasizes how cancer genetics may vary between populations, highlighting the importance of region-specific genomic data.
A Notable Milestone
Development of the “HOPE” genetic screening chip
Among Dr. Al-Kuraya’s notable scientific contributions is the development of a gene-testing platform known as the “HOPE” chip. This diagnostic chip was designed to analyze a matrix of 35 cancer-related genes associated with inherited cancer risk. The platform allows clinicians to screen for hereditary cancer susceptibility using a relatively simple and cost-effective test.
The concept behind the HOPE chip is similar to preventive screening programs: identifying individuals who carry certain genetic mutations before disease develops. Early detection of inherited cancer risk can support:
- Preventive monitoring programs
- Earlier clinical intervention
- Personalized risk-reduction strategies
This work reflects Dr. Al-Kuraya’s broader research philosophy: applying genomic science in ways that directly benefit public health and clinical care.
A Career Built on Growth and Academic Leadership
Dr. Khawla Al-Kuraya has played a major role in developing cancer genomics research infrastructure in Saudi Arabia. Her leadership spans laboratory science, clinical oncology programs, and national research initiatives. Her key positions include:
- Chief Cancer Research Scientist, King Faisal Specialist Hospital & Research Centre (Riyadh)
- Director — Human Cancer Genome Research Program, King Faisal Specialist Hospital & Research Centre
- Director — King Fahd National Center for Children’s Cancer and Research, operating within KFSH&RC since 2005
- Consultant and Principal Clinical Scientist, King Faisal Specialist Hospital & Research Centre (since 2002)
- Professor — College of Medicine, King Faisal University, Riyadh
She is widely recognized as a translational scientist, meaning her work links discoveries made in laboratory research to real clinical applications in cancer diagnosis and treatment. Through these roles, she has helped expand Saudi Arabia’s research capacity in genomic medicine, molecular diagnostics, and precision oncology.
Global Research Collaboration
Dr. Al-Kuraya also contributes to international scientific collaborations focused on mapping the genetic basis of cancer. She serves as a project director within the International Cancer Genome Consortium (ICGC), a global research initiative involving approximately seventy research groups worldwide. The consortium aims to map the genetic mutations that drive different types of cancer.
Within this international effort, she leads the Saudi research project focused on the genetic mapping of thyroid cancer, contributing regional data to global cancer genome studies. Her participation in the consortium connects Saudi cancer research with international genomic science networks.
Public Service and National Engagement
Beyond her scientific leadership, Dr. Al-Kuraya has also served in national public service roles. In 2013, she was selected among the first thirty women appointed to the Saudi Shura Council, marking the historic inclusion of women in the advisory legislative body. She served in this role until 2017, contributing to national discussions related to science policy, education, and healthcare development. Her appointment reflected the increasing recognition of scientific expertise in national policy discussions.
Honors and Recognition
Dr. Al-Kuraya’s scientific contributions have been recognized through several national and international awards.
- Order of King Abdulaziz (First Class), 2010 — awarded by King Abdullah for outstanding scientific achievement; she became the first Saudi woman to receive this honor
- Harvard University Excellence Award, 2007 — recognizing her discovery of genetic fingerprints in cancer patients
- Recognition among leading Arab biomedical scientists and cancer researchers
These honors reflect the impact of her research on cancer genetics and her role in strengthening Saudi Arabia’s biomedical research community.
Looking Ahead
Cancer genomics is becoming one of the most influential fields in modern medicine. Advances in genetic sequencing and precision medicine are transforming how cancers are diagnosed and treated. Saudi Arabia is increasingly investing in genomic research and biotechnology infrastructure. Within this landscape, Dr. Khawla Al-Kuraya’s work continues to play a key role in building scientific capacity and advancing cancer research.
Through her leadership in cancer genomics, she has helped establish Saudi Arabia as a contributor to global efforts aimed at understanding and treating cancer at the molecular level. Her career demonstrates how physician-scientists can connect research, clinical care, and national innovation systems, ensuring that scientific discovery leads to better outcomes for patients.
To follow Dr. Khawla Al-Kuraya’s work, visit King Faisal Specialist Hospital & Research Centre.
